Skip to main content
. Author manuscript; available in PMC: 2011 Apr 14.
Published in final edited form as: Ann Thorac Surg. 2010 Feb;89(2):440–445. doi: 10.1016/j.athoracsur.2009.10.059

Figure 1.

Figure 1

Figure 1

Figure 1

Intracerebral glutamate levels (μM) over time with and without MK-801 treatment (figure 1A). Intracerebral glycine levels (μM) (figure 1B) and intracerebral citrulline levels (μM) (figure 1C) over time with and without MK-801 treatment. *, p<0.05 compared to baseline. **, p<0.05 compared to HCA without MK-801 treatment.